EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Xanthohumol: Mechanistic Actions and Emerging Evidence as a Multi-Target Natural Nutraceutical

Mackenzie Azuero, Camilla F Wenceslau iD, Wenbin Tan iD

Nutrients · 2026

DOI: 10.3390/nu18030520 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Mackenzie Azuero und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA. Hauptthemen laut MEDLINE: Propiophenones, Flavonoids, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH Common Fund, United States Department of Defense, the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Xanthohumol (XN), a prenylated chalcone flavonoid derived from hops (Humulus lupulus), is increasingly recognized as a highly pleiotropic natural compound.

Objective

We aimed to structure XN’s mechanistic hierarchy with emerging translational relevance across disease areas.

Methods

We performed a comprehensive and integrative literature review of XN for its biological and translational effects across cancer, metabolic, neurological, cardiovascular, hepatic, renal, and dermatological disorders.

Results

Mechanistically, XN exerts diverse bioactivities by inhibiting major pro-oncogenic and pro-inflammatory pathways, such as NF-κB, PI3K/Akt/mTOR, STAT3, HIF-1α, and selective MAPK cascades, while activating cytoprotective signaling, such as the Nrf2/ARE and AMPK pathways. Through these coordinated actions, XN modulates redox homeostasis, mitochondrial integrity, apoptosis, autophagy, ferroptosis, and inflammatory responses. In oncology, XN demonstrates broad-spectrum anticancer activity in preclinical models by inhibiting proliferation; inducing cell cycle arrest and apoptosis; suppressing epithelial–mesenchymal transition, angiogenesis, and metastasis; and restoring chemosensitivity in resistant cancers, including breast, lung, gastric, liver, and head-and-neck carcinomas. Beyond cancer, XN exhibits multi-organ protective bioactivities through antioxidative, antimicrobial, antiviral, and anti-inflammatory activities; inhibition of ferroptosis and excitotoxicity; and preservation of mitochondrial integrity. It shows beneficial effects in preclinical models of Parkinson’s disease, Alzheimer’s disease, hepatic steatosis and fibrosis, renal ischemia–reperfusion injury, cardiovascular dysfunction, skin photoaging, and atopic dermatitis. Human subject studies demonstrate that XN is safe and well tolerated, with observed reductions in oxidative DNA damage and inflammatory cytokine release. Recent advances in micellar formulations have improved XN’s systemic bioavailability and thus its translational feasibility.

Conclusions

In summary, XN is a safe, multifunctional natural compound with strong potential for modulating disease-relevant biological pathways associated with cancer, neurodegenerative diseases, metabolic disorders, and inflammatory skin conditions. Continued efforts to enhance its bioavailability and conduct rigorous clinical trials are essential to fully establish its clinical relevance in patient populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropiophenonesFlavonoidsDietary SupplementsHumansAnimalsHumulusSignal TransductionAnti-Inflammatory AgentsNeoplasmsSkin Diseases

Stichwörter der Autor:innen

NF-κBNrf2anti-inflammationantioxidantxanthohumol

Substanzen

xanthohumolPropiophenonesFlavonoidsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
  • Department of Biomedical Engineering, College of Engineering and Computing, University of South Carolina, Columbia, SC 29208, USA.
  • The Cardiovascular Translational Research Center, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.

ORCID-Profile: Camilla F Wenceslau, Wenbin Tan

Förderung

  • NIH Common Fund
  • United States Department of Defense
  • the National Institutes of Health
  • Department of Defense
  • the University of South Carolina School of Medicine Bridge Funding

Zitieren

APA

Azuero, M., Wenceslau, C. F., & Tan, W. (2026). Xanthohumol: Mechanistic Actions and Emerging Evidence as a Multi-Target Natural Nutraceutical. Nutrients. https://doi.org/10.3390/nu18030520

Vancouver

Azuero M, Wenceslau CF, Tan W. Xanthohumol: Mechanistic Actions and Emerging Evidence as a Multi-Target Natural Nutraceutical. Nutrients. 2026. doi:10.3390/nu18030520

BibTeX
@article{Azuero2026,
  author = {Azuero, Mackenzie and Wenceslau, Camilla F and Tan, Wenbin},
  title = {Xanthohumol: Mechanistic Actions and Emerging Evidence as a Multi-Target Natural Nutraceutical},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18030520}
}
Kostenlos starten →